| INTRODUC TI ON
There has been a considerable shift in cancer care from inpatient admissions to more outpatient visits and ambulatory care (Berglund, Gustafsson, Johansson, & Bergenmar, 2015) . This results in a higher number of patients being treated in day care and highlights the need for increased timeliness and efficiency at cancer day care units (CDUs). As a result, concepts such as lean and business process management are making their way into the sector (D'Andreamatteo, Ianni, Lega, & Sargiacomo, 2015; Manfreda, Kovacic, Štemberger, & Trkman, 2014) . These studies have led to several suggestions for improvement, such as collecting the blood samples during an outpatient visit one or more days before the day care treatment (Day −1), in order to prepare the anticancer medication in advance. This leads to a reduction in patient throughput time in the CDU on the day of treatment (Day 0) and increases the number of patients that can be treated per day (van Lent, Goedbloed, & Van Harten, 2009). Another approach to reducing throughput time is dose banding (Huertas et al., 2015; Masselink, van der Mijden, Litvak, & Vanberkel, 2012) , which refers to a method that uses predefined ranges (bands) of body surface area (BSA) to calculate each patient's dose as a single BSA value per band. This principle can only be applied to drugs with sufficient long-term stability. Dose banding and taking the blood sample on Day −1 can both be considered process redesign initiatives.
Despite the growing recognition and acceptance of the need to embrace patient-centred care approaches (Masselink et al., 2012) , healthcare studies have paid limited attention to the patient perspective in process redesign initiatives (Moraros, Lemstra, & Nwankwo, 2016) . Most studies have focused merely on the collection of operational metrics, such as patient throughput time and the number of operational failures (McIntosh, Sheppy, & Cohen, 2014) , but have neglected "the patient's perspective" as a measure. This study instead aims to integrate the patient perspective into the operational analysis and design of hospital processes in cancer care.
Abstract
This study was designed to focus on the patient perspective in a reorganisation of care processes at a cancer day care unit (CDU). The effects of dose banding and of taking blood samples one day (or more) before the day care treatment (on Day −1) are investigated in terms of throughput efficiency and perceived service quality. Data were collected by mapping patient processes in detail and surveying patients in two CDUs at a university hospital (n = 308). A univariate model was used to investigate the effect of these factors on patient throughput time, and perceived service quality was examined with multiple linear regression. Taking blood samples on Day −1 decreases patient throughput time and increases the perceived service quality by improving the patient's perception of technical expertise and the outcome. This has a globally positive effect on patients' perceived service quality. Dose banding affected neither patient throughput time nor perceived service quality. Taking the pretreatment blood sample on Day −1 can be considered an important process design characteristic, as it increases both efficiency and service quality.
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cancer care facilities, efficiency, organisational, outpatient clinics, process (re)design, service quality The objective of this study was to measure the effect of dose banding and taking the blood sample on Day −1 in two CDUs on both the throughput efficiency of the department and on the service quality perceived by patients. The efficiency will be studied by examining throughput time from the arrival of the patient in the CDU to the initiation of therapy. The perceived service quality is examined by means of a patient survey investigating patients' opinion of the service quality of the department. This study investigates whether this process redesign at the CDU results in an improved service quality as perceived by the patient.
| ME THOD

| Procedure
Data were collected during one week in April 2015 (n = 163) and 1 week in November 2015 (n = 145) at two CDUs in a university hospital. The study was approved by the medical ethics committee.
Observations, document analysis and six semistructured interviews were carried out in order to develop a process travel sheet for each department. Each patient process was documented by filling out the process travel sheet. CDU staff and the hospital pharmacy collected time and process data on each patient. Patients filled out a survey coupled to the process travel sheets in order to collect data from the patient perspective. Data from 780 patient processes were gathered. Data from the survey were available for 40% of these processes, as patients visited the clinic twice and left out data in the responses.
| Measures
The process travel sheet followed the patient process in the CDU to collect data on time points in the treatment process (e.g., arrival in the department, contact with the physician and initiation of treatment). The travel sheet also identified whether the patient's blood sample was taken on Day −1 or on Day 0.
Data related to the process of anticancer drug preparation at the pharmacy were also collected and allowed us to identify whether dose banding was used. Other variables gathered on the process travel sheets were the CDU, the cancer type and the type of medication. The service quality scale of Dagger, Sweeney, and Johnson (2007) 
| Statistical analysis
Since the data were not normally distributed (Kolmogorov-Smirnoff test: p < 0.05), a log transformation was performed for patient throughput time and perception variables were centralised. The validity of the constructs was assessed using confirmatory factor analysis. The measurement model for the sample performed well without the operational subdimension. The sample showed convergent validity and adequate construct validity. Since the measurement model performed well, in the further analysis, we used mean scores for interpersonal quality, technical quality, environmental quality, administrative quality and the perceived service satisfaction in relation to the CDU. The effect of the new process characteristics (dose banding and taking the blood sample on Day −1) on waiting time was statistically evaluated using a general univariate linear model with the univariate GLM dialog (Levene's test: p = 0.148) with the factors dose banding (two factors) and day of blood sample (two factors). The effect of the quality dimensions of service quality and redesign characteristics on perceived service quality were analysed using multiple linear regression.
| RE SULTS
The descriptive results show a difference in population between the two departments (see Table 1 ). In 14.9% of processes, medication was prepared by dose banding, and in 41.9% of the cases, the blood sample was taken on Day −1. As shown in Table 2 , significant relationships were observed between all quality dimensions and the perceived service quality. Only technical quality correlated with patient throughput time.
| Effect of redesign initiatives on patient throughput time
The time of blood sampling had a significant effect on throughput time (F = 32.859; p < 0.001; part.ŋ 2 = 0.105). There was no significant effect of dose banding (F = 0.495; p = 0.482; part.ŋ 2 = 0.002; see Table 3 ). There was no interaction effect between the mo- 
| Effect of redesign initiatives on service quality perception
Based on the hierarchical analysis, the control variables (moment of data collection and department) showed no significance, F(3, 255) = 2.278; p = 0.079, Adj.R 2 = 0.02 and were not added to the model.
We searched for the best-fitting model based on a significant R 2 change (see Table 4 ). The model with only environmental quality, technical quality, and administrative quality as independent variables explained 62.9% of the variance in perceived service quality.
This change in R 2 became significant (p = 0.007) when the interaction of taking the blood sample on Day −1 and technical quality was added. The final model explained 63.7% of the variance in perceived service quality. Technical quality is the most important quality dimension (B = 0.688), followed by administrative quality (B = 0.138) and environmental quality (B = 0.097). When the blood sample was taken on Day −1, the perceived service quality per unit change in technical quality was on average 0.263 higher than when the blood sample was not taken in advance.
| D ISCUSS I ON
The results of this study demonstrate the effect of process design characteristics on the efficiency and quality of an organisation.
Taking the blood sample on Day −1 does significantly decrease patient throughput time before the initiation of therapy on Day 0. Throughput efficiency is thus increased and more patients can be treated per day at the department, which is an important performance measure for CDUs. This throughput time also includes waiting time for the patient, which has been identified in previous research as being not valuable for the patient and should thus be reduced (Masselink et al., 2012; Turkcan, Zeng, & Lawley, 2012; van Lent et al., 2009; Vanberkel et al., 2010) .
On the other hand, dose banding has no significant effect on patient throughput time, although it has been identified as a strategy for accelerating in-hospital turnaround time for commonly used preparations that contribute to enhanced daily patient capacity in oncology clinics (Hoppe-Tichy, 2009 does reduce throughput time in the pharmacy (Claus et al., 2018) , improving organisational processes there, but so far the impact on the patient process in the CDU seems to be limited.
We also investigated the impact of the redesign characteristics on the perceived service quality of the patient. As such, our study contributes to the debate on how measurements of patients' perceptions help understand the patient experience with regard to oncology processes. This is an important topic in the current discussion on patient-reported experience measures (PREMs; Luckett, Butow, & King, 2009 ). Most variance in perceived service quality was explained by technical quality. Environmental quality and administrative quality were also significant, but interpersonal quality surprisingly was not. This is not in line with the report of Dagger et al. (2007) , who found that interpersonal quality had a significant effect on perceived service quality in a private outpatient oncology clinic. However, interpersonal quality and technical quality are both terms used to describe the competence of the medical staff. It may be that patients focus more on the technical quality than on the interpersonal quality on account of the setting. The study was carried out in a university hospital, which has more expertise in complex diseases and the administration of complex multiagent chemotherapy protocols. Because of the severity and complexity of the individual cases, patients may focus more on technical quality rather than interpersonal quality. As expected, dose banding did not influence the Note. The best-fitting model based on a significant R 2 was used to determine the most parsimonious model of perceived service quality. Model 1 evaluates administrative quality, technical quality and environmental quality as the independent variables and explained 62.9% of the variance in perceived service quality (p < 0.001). Model 2, also considering the interaction effect of technical quality and the day the blood sample was taken, explained 63.7% of the variance in perceived service quality with a significant R 2 change (p = 0.007).
TA B L E 4 Multiple linear regression
perceived service quality, as dose banding is an organisational issue that is not discussed with the patient prior to treatment, meaning the patient is not aware of whether dose banding is used to prepare the medication.
When a blood sample is taken on Day −1, the average increase in perceived service quality per unit change in technical quality is 0.202 greater than when the blood sample is not taken in advance. Although more effort is required from patients who must visit the hospital twice (or pay an additional visit to a general practitioner), it nonetheless affects the perception of technical quality positively. This might be explained by the fact that the blood sample is taken in a different professional environment. On Day −1, the patient is typically seen by a nurse and a physician who discuss the treatment experience in a more general way, without focusing exclusively on the administration of anticancer drugs. Hence, the individual time spent with a practitioner on at a separate point in time is valuable for a patient.
This study has several limitations. Our response rate (40%) was not high, but is nonetheless reasonable, given the requirement that both the survey and process travel sheet needed to be filled out correctly. The study was performed at only two CDUs at a single university hospital. This rather small sample size restricts the interpretation and generalisation of the results. The quantitative method to measure perceived service satisfaction gives less information about why patients perceive technical quality better when the blood sample is taken on Day −1. A qualitative study could give more insight into this.
Despite its limitations, the results of this study highlight several key aspects that should be considered in the design of cancer care services. The implementation of dose banding might improve performance in the pharmacy department, but has no significant impact on the CDU. On the other hand, taking blood samples taken on Day −1 has a positive effect on both the patient throughput time and the perceived service quality. The throughput time of an individual patient is thus reduced, and more patients can be treated in a single day. Although taking the blood sample on Day −1 requires an extra effort from the patients, who must visit a professional twice, this nonetheless increases the perceived service quality. In conclusion, the efficiency of the CDU and the service quality, as perceived by the patient, can be considered to be two sides of the same coin.
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